Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Entheon Biomedical
€0.07
0
+€0
+0%
Thursday 06:24
1D
1W
1M
3M
1Y
5Y
Add to Watchlist
Statistics
Day High
0.07
Day Low
0.07
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 1XU.F. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap
511.54M
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, similar to Entheon's focus on psychedelic therapies.
Mind Medicine
MNMD
Mkt Cap
493.47M
Mind Medicine works on developing psychedelic-inspired therapies, directly competing with Entheon's approach in mental health treatment.
ATAI Life Sciences N.V.
ATAI
Mkt Cap
218.14M
ATAI Life Sciences is a biotech company developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Entheon's market.
GH Research
GHRS
Mkt Cap
546.3M
GH Research focuses on developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Cybin
CYBN
Mkt Cap
194.47M
Revive Therapeutics
RVVTF
Mkt Cap
3.99M
Revive Therapeutics explores psilocybin-based therapies, which is a direct competition to Entheon's psychedelic research and development.
Mydecine Innovations Group
MYCOF
Mkt Cap
649,542
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same niche as Entheon.
Seelos Therapeutics
SEEL
Mkt Cap
2.04M
Seelos Therapeutics works on projects including ketamine-based treatments, which competes with Entheon's psychedelic-based therapeutic approaches.
About
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Timothy Ko
Employees
2
Country
CA
ISIN
CA29383X2023
WKN
000A404YT
Listings
F
DE
1XU.F
US
ENTBF
CN
CA
ENBI.CN
Add to Watchlist